Eli Lilly & Co: (NYSE: LLY)
$55.14
0.12 (0.22%)
Volume 4,218,428
04:01 PM ET
Zacks Rank: 3-Hold 
BROKERAGE REPORTS
0 items in cart
LILLY ELI & CO [LLY]
Reports for Purchase
Showing records 1 - 20 ( 45 total )
|
Price: 24.95
|
|
Price: 24.95
|
|
Company: LILLY ELI & CO Industry: LARGE CAP PHARMA The Zyprexa Patent Expiration Has Largely Run Its Course Provider: J.J.B. Hilliard, W.L. Lyons Analyst: O'NEIL S
Price: 25.00 |
|
Price: 24.95
|
|
Price: 24.95
|
|
Company: LILLY ELI & CO Industry: LARGE CAP PHARMA Third Quarter Results Provider: J.J.B. Hilliard, W.L. Lyons Analyst: O'NEIL S
Price: 25.00 |
|
Price: 24.95
|
|
Company: LILLY ELI & CO Industry: LARGE CAP PHARMA Health Care Looking Solid Ahead of Election Provider: DREXEL HAMILTON, LLC Analyst: SINE B
Price: 25.00 |
|
Price: 24.95
|
|
Price: 24.95
|
|
Company: LILLY ELI & CO Industry: LARGE CAP PHARMA Solid Execution Overshadowed by Zyprexa Patent Expiration Provider: J.J.B. Hilliard, W.L. Lyons Analyst: O'NEIL S
Price: 25.00 |
|
Company: LILLY ELI & CO Industry: LARGE CAP PHARMA Griffin Securities Updates Coverage on Ligand Pharma. (LGND) Provider: GRIFFIN SECURITIES, INC. Analyst: MARKEY K
Price: 75.00 |
|
Price: 24.95
|
|
Price: 24.95
|
|
Company: LILLY ELI & CO Industry: LARGE CAP PHARMA Revenue down as Expected. First Quarter EPS Handily Exceeded Expectations Provider: J.J.B. Hilliard, W.L. Lyons Analyst: O'NEIL S
Price: 25.00 |
|
Company: LILLY ELI & CO Industry: LARGE CAP PHARMA 2012 AACR Planner, Check. Next Stop, Chicago Provider: Rodman & Renshaw, Co. Analyst: PIROS E
Price: 50.00 |
|
Price: 24.95
|
|
Price: 24.95
|
|
Company: LILLY ELI & CO Industry: LARGE CAP PHARMA Fourth Quarter Results Felt the Impact of the Zyprexa Patent Expiration. Provider: J.J.B. Hilliard, W.L. Lyons Analyst: O'NEIL S
Price: 25.00 |
|
Price: 24.95
|
